BIONEXT models drug development

February 17, 2015

Press Release from BPI France

The company located in Strasbourg combines biotechnologies and mathematical models derived from information technologies. The aim is to better manage risks on very heavy investments undertaken by pharmaceutical companies.

See more: Source